Carnegie Mellon University

Institutional Biosafety Committee (IBC)

The IBC is responsible for monitoring and ensuring the compliance of Carnegie Mellon University (CMU) laboratories with the NIH Guidelines, as well as for reviewing and approving of all research projects involving recombinant/synthetic nucleic acid molecules. 

Carnegie Mellon's Department of Environmental Heath and Safety (EHS) recognizes that manipulation and insertion of recombinant/synthetic nucleic acids into various organisms is an integral part of many of CMU’s research and teaching laboratories.

Contact Us

Email Icon

Phone Icon 412-268-8182

Administrative office: 412-268-5609

What are considered Recombinant and Synthetic Nucleic Acid Molecules?

In the context of the NIH Guidelines, the definition of recombinant and synthetic nucleic acids can be found in section I-B.


Recombinant and Synthetic Nucleic Acids Research Applications

To register a new project, modify an existing project or renew approval of a current project, please use the research application.

Any human subject or animal research MUST go through the Office of Research Integrity and Compliance.

To file for exemption from the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, please complete the exemption form.

Please contact the Biological Safety Officer for any questions.

Training for Research Pertaining to the NIH Guidelines

bacterial transformation

Required: For all persons whose research involves the use or manipulation of recombinant or synthetic nucleic acids as defined by the NIH Guidelines.

Course: Overview of the Current NIH Guidelines for Research Involving Recombinant DNA Molecules